BioMarin Announces Fourth Quarter and Full Year 2015 Financial Results
February 25, 2016 16:02 ET
|
BioMarin Pharmaceutical Inc.
- Full-year 2015 Total BioMarin Revenue Increases 18.8% to $889.9 million Year-over-Year - Vimizim Net Product Revenue Contributes Over $228 million to 2015 Top-line - Full-year 2016 Total...